Viking Therapeutics initiates VANQUISH phase 3 obe...
Category : Clinical Trial Update 26 June 2025Overview Viking Therapeutics, Inc. (Viking), a clinical-stage biopharmaceutical company focused o...
Clinical Trial Update
Amgen announces phase 2 obesity study results of M...
Category : Clinical Trial Update 26 June 2025Overview Amgen, announced full results from part 1 of the phase 2 study of MariTide (maridebart c...
Stuart Therapeutics gives Initial Results of Phase...
Category : Clinical Trial Update 26 June 2025Overview Stuart Therapeutics, Inc., a clinical-stage drug platform company developing novel thera...
Chugai Pharma presents positive data from NXTAGE p...
Category : Clinical Trial Update 25 June 2025Overview Chugai Pharmaceutical Co., Ltd. announced that the first clinical data in people with ha...
Merck’s phase 3 HYPERION study of Winrevair meets...
Category : Clinical Trial Update 25 June 2025Overview Merck, known as MSD outside of the United States and Canada, today announced positive to...
Latest Newsletter Post
-
Stuart Therapeutics gives Initial R..
26 June 2025
-
Amgen announces phase 2 obesity stu..
26 June 2025
-
Viking Therapeutics initiates VANQU..
26 June 2025
-
Spinogenix Announces Full Enrollmen..
25 June 2025
-
Merck’s phase 3 HYPERION study of W..
25 June 2025
Subscribe to Our Newsletter!
C-89, Sector-65 Noida-U.P. 201301 (India)
Phone: +91-120-6631301-361
Mobile: +91-9990237670
Customer Care: 18004190155
Email: info@lifescienceintellipedia.com
Email: sales@lifescienceintellipedia.com